$IMMX

$8.05 -$0.01 (0.12%) Close

$IMMX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$IMMX Management Team

Dr. Ilya Rachman

Chairman of the Board

Chief Executive Officer

Age 53

Compensation $1.267M USD

Sex Male

Dr. Vladimir Torchilin

Scientific Co-Founder

Age 78

Compensation -

Sex Male

Mr. Gabriel Morris

Chief Financial Officer

Director

Age 39

Compensation $1.267M USD

Sex Male

Dr. Graham Ross

Acting Chief Medical Officer

Head - Clinical Development

Age 65

Compensation $88.59K USD

Sex Male

Name / Title	Age	Compensation	Sex
Dr. Ilya Rachman Chairman of the Board Chief Executive Officer	53	$1.267M USD	Male
Dr. Vladimir Torchilin Scientific Co-Founder	78	-	Male
Mr. Gabriel Morris Chief Financial Officer Director	39	$1.267M USD	Male
Dr. Graham Ross Acting Chief Medical Officer Head - Clinical Development	65	$88.59K USD	Male

Board of Directors

From the proxy statement filed Apr 6, 2026

Directors

serving now

Independent

5 of 5

stated in the proxy; 4 not stated

Average tenure

5.5 years

from year joined

CEO also chairs the board

Yes

Ilya Rachman

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Ilya Rachman Board chair, CEO, Executive officer	54	Not stated	Not stated	None stated	None stated	Paid as CEO
Gabriel Morris Executive officer	40	2021 5 years	Not stated	None stated	None stated	Not stated
Jason Hsu	52	2013 13 years	Independent	Compensation Committee	None stated	Not stated
Magda Marquet	67	2021 5 years	Independent	Compensation Committee · Chair	AnaptysBio, Inc.	$107,496
Helen C. Adams	67	2021 5 years	Independent	Audit Committee · Chair	None stated	$125,996
Carey Ng	47	2019 7 years	Independent	Audit Committee	None stated	$100,996
Jane Buchan	62	2021 5 years	Independent	Audit Committee	AGF Management Ltd.	$113,996
Yekaterina Chudnovsky	41	2023 3 years	Not stated	None stated	Elicio Therapeutics, Inc.	$95,496
Nancy Chang	76	2025 1 year	Not stated	None stated	Galera Therapeutics, Inc.	$458,197

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

1 disclosed in the proxy filed Apr 6, 2026

Robinhood II, LP

Nancy Chang is the general manager of Robinhood II, LP and in such capacity has the right to vote and dispose of the securities held by such entity

Amount not stated

fiscal 2025

Marketing services and investor relations agreement; Company paid cash and issued common stock to Robinhood II, LP for marketing services

With the Company Open in proxy

Comments

Company Executives

$IMMX Management Team

Dr. Ilya Rachman

Dr. Vladimir Torchilin

Mr. Gabriel Morris

Dr. Graham Ross

Board of Directors

Related-party transactions